Pfizer Drops Lead Obesity Asset After Liver Safety Concerns, Overall Review
Pfizer will no longer invest in the development of its oral GLP-1 drug danuglipron after the pharma detected a potential...
Pfizer will no longer invest in the development of its oral GLP-1 drug danuglipron after the pharma detected a potential...
Janis Reeser | AI-assisted reporterMARTINSBURG, WV — WVU Medicine Berkeley Medical Center is now offering a new treatment for liver...
Kingston Health Sciences Centre (KHSC) is now home to one of the most advanced treatments for liver cancer in Canada....
By Paul Brockwell Seung Duk Lee, M.D., Ph.D., associate surgical director of liver transplants for the VCU Health Hume-Lee Transplant...
It was recognised as the Tertiary Hospital of the Year - Pakistan and the Specialty Hospital of the Year -...
Colorectal cancer is one of the most common cancers among both men and women in the U.S. While it’s very...